terfenadine has been researched along with Heart Septal Defects, Ventricular in 1 studies
Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.
Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kothari, SS | 1 |
| Sharma, S | 1 |
| Wasir, HS | 1 |
1 other study available for terfenadine and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
Terfenadine overdose induced polymorphous ventricular tachycardia.
Topics: Child; Drug Overdose; Heart Septal Defects, Ventricular; Histamine H1 Antagonists; Humans; Male; Pos | 1995 |